Viatris Inc.: all 777 studies

Page 6 of 8. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.

• Fasting Study of Fluoxetine Capsules 40 mg and Prozac Pulvules 40 mgCompletedNCT00649636Phase 1
• Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mgCompletedNCT00649623Phase 1
• Fasting Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mgCompletedNCT00649597Phase 1
• Fasting Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mgCompletedNCT00649571Phase 1
• Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mgCompletedNCT00649558Phase 1
• Fasting Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mgCompletedNCT00649532Phase 1
• Fasting Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mgCompletedNCT00649519Phase 1
• Food Study of Nitrofurantoin Macrocrystals 100 mg Capsules and Macrodantin® 100 mgCompletedNCT00649506Phase 1
• Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mgCompletedNCT00649493Phase 1
• Fed Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mgCompletedNCT00649480Phase 1
• Applesauce Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mgCompletedNCT00649467Phase 1
• Fasting Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mgCompletedNCT00649454Phase 1
• Fasting Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mgCompletedNCT00649441Phase 1
• Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mgCompletedNCT00649402Phase 1
• Fasting Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mgCompletedNCT00649376Phase 1
• Fasting Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mgCompletedNCT00649363Phase 1
• Food Study Metformin Hydrochloride ER Tablets 750 mg and Glucophage XR 750 mgCompletedNCT00649350Phase 1
• Fasting Study of Hydrochlorothiazide Tablets 50 mg to Hydrochlorothiazide Tablets 50 mgCompletedNCT00649324Early Phase 1
• Food Study of Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mgCompletedNCT00649285Phase 1
• Fasting Study of Oxybutynin Chloride Extended-Release Tablets 15 mg and Ditropan XL® Tablets 15 mgCompletedNCT00649272Phase 1
• Food Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mgCompletedNCT00649259Phase 1
• Food Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg to Lopressor HCT® Tablets 100/50 mgCompletedNCT00649233Phase 1
• Food Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Tablets 20 mgCompletedNCT00649194Phase 1
• Fasting Study of Metolazone Tablets 5 mg and Zaroloxyn® Tablets 5 mgCompletedNCT00649181Phase 1
• Fed Study of (Parlodel®) Bromocriptine Mesylate Capsules 5 mgCompletedNCT00649168Phase 1
• Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mgCompletedNCT00649155Phase 1
• Fasting Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mgCompletedNCT00649129Phase 1
• Fed Study of Metoprolol Tartrate Tablets 100 mg and Lopressor® 100 mgCompletedNCT00649116Phase 1
• Fasting Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mgCompletedNCT00649103Phase 1
• Fasting Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mgCompletedNCT00649077Phase 1
• A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic DrugsCompletedNCT00649064Phase 4
• Fasting Study of Metolazone Tablets 2.5 mg and Zaroloxyn® Tablets 2.5 mgCompletedNCT00649051Phase 1
• Fed Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mgCompletedNCT00649038Phase 1
• Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mgCompletedNCT00649012Phase 1
• Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting StateCompletedNCT00648960Phase 1
• Fasting Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mgCompletedNCT00648947Phase 1
• Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mgCompletedNCT00648934Phase 1
• Fasting Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mgCompletedNCT00648921Phase 1
• Fasting Study of Levothyroxine Sodium Tablets 300 mcg to Synthroid® Tablets 300 mcgCompletedNCT00648882Phase 1
• Food Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mgCompletedNCT00648856Phase 1
• Food Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mgCompletedNCT00648843Phase 1
• Comparative Bioavailability Study of Clarithromycin 250 mg TabletsCompletedNCT00648830Phase 1
• Food Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mgCompletedNCT00648804Phase 1
• Fasting Study of Finasteride Tablets 5 mg and Proscar Tablets 5 mgCompletedNCT00648791Phase 1
• Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mgCompletedNCT00648778Phase 1
• Fed Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mgCompletedNCT00648765Phase 1
• Fed Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® 250 mgCompletedNCT00648713Phase 1
• Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300 μgCompletedNCT00648700Phase 1
• Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mgCompletedNCT00648661Phase 1
• Fed Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mgCompletedNCT00648622Phase 1
• A Study to Evaluate Self-esteem and Relationships in Males With Erectile DysfuntionCompletedNCT00648596Phase 4
• Food Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mgCompletedNCT00648583Phase 1
• Fasting Study of Escitalopram Oxalate Tablets 20 mg and Lexapro® Tablets 20 mgCompletedNCT00648570Phase 1
• Fasting Study of Levothyroxine Sodium Tablets 200 mg to Synthroid Tablets 200 mgCompletedNCT00648557Phase 1
• Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In SubjectsCompletedNCT00648544Phase 1
• Fasting Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mgCompletedNCT00648531Phase 1
• Fasting Study of Metformin Hydrochloride ER Tablets 750 mg and Glucophage® XR Tablets 750 mgCompletedNCT00648518Phase 1
• Food Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mgCompletedNCT00648505Phase 1
• Food Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR 500 mgCompletedNCT00648492Phase 1
• Fasting Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mgCompletedNCT00648466Phase 1
• Food Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mgCompletedNCT00648440Phase 1
• Fasting Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mgCompletedNCT00648427Phase 1
• Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hrTerminatedNCT00648414Phase 1
• Food Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mgCompletedNCT00648401Phase 1
• Fasting Study of Cilostazol Tablets 100 mg and Pletal® Tablets 100 mgCompletedNCT00648388Phase 1
• Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mgCompletedNCT00648362Phase 1
• Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mgCompletedNCT00648349Phase 1
• Fasting Study of Mercaptopurine 50 mg and Purinethol® Tablets 50 mgCompletedNCT00648336Phase 1
• Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate EnlargementCompletedNCT00648323Phase 4
• Fed Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mgCompletedNCT00648297Phase 1
• Fed Study of Metoprolol Tartrate Tablets 25 mg and Lopressor® 50 mgCompletedNCT00648271Phase 1
• Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mgCompletedNCT00648219Phase 1
• Fasting Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mgCompletedNCT00648193Early Phase 1
• Food Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mgCompletedNCT00648180Phase 1
• Food Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mgCompletedNCT00648154Phase 1
• Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed StateCompletedNCT00648128Phase 1
• Food Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mgCompletedNCT00648076Phase 1
• Fasting Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mgCompletedNCT00648063Phase 1
• Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg to Verelan® PM Extended-Release Capsules 300 mgCompletedNCT00648050Phase 1
• Fasting Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mgCompletedNCT00648024Phase 1
• Food Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mgCompletedNCT00648011Phase 1
• Food Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mgCompletedNCT00647985Phase 1
• Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mgTerminatedNCT00647972Phase 1
• Fasting Study of Doxycycline Monohydrate Tablets 150 mg and Adoxa Tablets 150 mgCompletedNCT00647959Phase 1
• Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mgCompletedNCT00647894Phase 1
• Food Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mgCompletedNCT00647881Phase 1
• Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μgCompletedNCT00647855Phase 1
• Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal SystemCompletedNCT00647842Phase 1
• Fasting Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mgCompletedNCT00647816Phase 1
• Food Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mgCompletedNCT00647777Phase 1
• Food Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mgCompletedNCT00647751Phase 1
• Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting StateCompletedNCT00647738Phase 1
• Fasting Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mgCompletedNCT00647712Phase 1
• Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System With Askina Derm OverlayCompletedNCT00647686Phase 1
• Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mgCompletedNCT00647673Phase 1
• Fasting Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mgCompletedNCT00647660Phase 1
• Fasting Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® Tablets 250 mgCompletedNCT00647647Phase 1
• Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mgCompletedNCT00647634Phase 1
• Steady-State Study of Extended Phenytoin Sodium Capsules 100 mg and Dilantin® Kapseals® 100 mgCompletedNCT00647621Phase 1
• Food Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mgCompletedNCT00647608Phase 1

← Viatris Inc. overview and focus areas